α3β4 nicotinic receptors in the medial habenula and substance P transmission in the interpeduncular nucleus modulate nicotine sensitization

Behavioural Brain Research

Volumn 316, Issue , 2017, Pages 94-103

  Eggan, Branden L ^a   McCallum, Sarah E ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Ezlopitant; Interpeduncular nucleus; Locomotor activity; Medial habenula; Microdialysis; Nicotine; Sensitization; Substance P receptor; Conotoxin AuIB; 3 4 nicotinic acetylcholine receptor

Indexed keywords

NEUROKININ 1 RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3BETA4; UNCLASSIFIED DRUG; BENZYLAMINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIHYDRO BETA ERYTHROIDINE; DOPAMINE; EZLOPITANT; FUSED HETEROCYCLIC RINGS; NICOTINIC AGENT; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; FEMALE; HABENULA; IN VIVO STUDY; INTERPEDUNCULAR NUCLEUS; LOCOMOTION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SENSITIZATION; ANALYSIS OF VARIANCE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; MICRODIALYSIS; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; BENZYLAMINES; BRIDGED BICYCLO COMPOUNDS, HETEROCYCLIC; CHOLINERGIC ANTAGONISTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIHYDRO-BETA-ERYTHROIDINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERPEDUNCULAR NUCLEUS; MICRODIALYSIS; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; SUBSTANCE P;

EID: 84985931300     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2016.08.028     Document Type: Article

References (47)

1. [1] Aizawa, H., Kobayashi, M., Tanka, S., Fukai, T., Okamoto, H., Molecular characterization of the subnuclei in rat habenula. J. Comp. Neurol. 520 (2012), 4015–4066.
2. [2] Antolin-Fontes, B., Ables, J.L., Gorlich, A., Ibanez-Tallon, I., The habenulo-interpeduncular pathway in nicotine aversion and withdrawal. Neuropharmacol 96 (2015), 213–222.
3. [3] Artymyshyn, R., Murray, M., Substance P in the interpeduncular nucleus of the rat: normal distribution and the effects of deafferentation. J. Comp. Neurol. 231 (1985), 78–90.
4. [4] Beiranvand, F., Zlabinger, C., Orr-Urtreger, A., Ristl, R., Huck, S., Schloze, P., Nicotinic acetylcholine receptors control acetylcholine and noradrenaline release in the rodent habenula-interpeduncular complex. Br. J. Pharmacol. 171 (2014), 5209–5224.
5. [5] Brownstein, M.J., Mroz, E.A., Kizer, J.S., Palkovits, M., Leeman, S.E., Regional distribution of substance P in the brain of the rat. Brain Res. 116 (1976), 299–305.
6. [6] Cho, K.H., Mori, S., Jang, H.S., Kim, J.H., Abe, H., Rodriguez-Vazquez, J.F., Murakami, G., The habenula-interpeduncular and mammillothalamic tracts: early developed fiber tracts in the human fetal diencephalon. Child's Nerv. Syst. 30 (2014), 1477–1484.
7. [7] Contestabile, A., Fonnum, F., Cholinergic and GABAergic forebrain projections to the habenula and nucleus interpeduncularis: surgical and kainic acid lesions. Brain Res. 275 (1983), 287–297.
8. [8] Cuello, A.C., Emson, P.C., Paxinos, G., Jessell, T., Substance P and cholinergic projections from the habenula. Brain Res. 149 (1978), 413–429.
9. [9] Dao, D.Q., Perez, E.E., Teng, Y., Dani, J.A., De Biasi, M., Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling. J. Neurosci. 34 (2014), 4273–4284.
10. [10] Eckenrode, T.C., Barr, G.A., Battisti, W.P., Murray, M., Acetylcholine in the interpeduncular nucleus of the rat: normal distribution and effects of deafferentation. Brain Res. 418 (1987), 273–286.
11. [11] Eggan, B.L., McCallum, S.E., 18-Methoxycoronaridine acts in the medial habenula to attenuate behavioral and neurochemical sensitization to nicotine. Behav. Brain Res. 307 (2016), 186–193.
12. [12] Elliot, P.H., Mason, G.S., Stephens-Smith, M., Hagan, R.M., Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Neuropeptides 19 (1991), 119–126.
13. [13] Fowler, C.D., Tuesta, L., Kenny, P.J., Role of α5 nicotinic acetylcholine receptors in the effects of acute and chronic nicotine treatment on brain reward function in mice. J. Psychopharmacol. 229 (2011), 503–513.
14. [14] Frahm, S., Slimak, M.A., Ferrarese, L., Santos-Torres, J., Antolin-f, B., Auer, S., Filkin, S., Pons, S., Fontaine, J.F., Tsetlin, V., Maskos, U., Ibanes-Tallon, I., Aversion to nicotine is regulated by the balanced activity of β4 and α5 nicotinic receptor subunits in the medial habenula. Neuron 70 (2011), 522–535.
15. [15] Gerfen, C.R., Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res. 556 (1991), 165–170.
16. [16] Glick, S.D., Sell, E.M., McCallum, S.E., Maisonneuve, I.M., Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administration. Eur. J. Pharmacol. 699 (2011), 71–75.
17. [17] Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guidicci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., Zoli, M., Structural and functional diversity of brain neuronal nicotinic receptors. Biochem. Pharmacol. 28 (2009), 703–711.
18. [18] Grady, S.R., Moretti, M., Zoli, M., Marks, M.J., Zanardi, A., Pucci, L., Clementi, F., Gotti, C., Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the α3β4 and α3β3β4 subtypes mediate acetylcholine release. J. Neurosci. 29 (2009), 2272–2282.
19. [19] Henderickson, L.M., Guildford, M.J., Tapper, A.R., Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence. Front. Psychiatry 4 (2013), 126–135.
20. [20] Herkenham, M., Nauta, W.J.H., Afferent connections of the habenular nuclei in the rat. A horseradish peroxidase study: with a note on the fiber-of-passage problem. J. Comp. Neurol. 173 (1977), 277–299.
21. [21] Hokflet, T., Pernow, B., Wahren, J., Substance P: a pioneer amongst neuropeptides. Intern. Med. 249 (2001), 27–40 J.
22. [22] Korotkova, T.M., Brown, R.E., Sergeeva, O.A., Ponomarenko, A.A., Haas, H.L., Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur. J. Neurosci. 23 (2006), 2677–2685.
23. [23] Luo, S., Kulak, J.M., Cartier, G.E., Jacobsen, R.B., Yoshikami, D., Olivera, B.M., McIntosh, M.J., α-Conotoxin AuIB selectively blocks α3β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J. Neurosci. 18 (1998), 8571–8579.
24. [24] Maeno, H., Kiyama, H., Tohyama, M., Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Mol. Brain Res. 18 (1993), 43–58.
25. [25] McCallum, S.E., Cowe, M.A., Lewis, S.W., Glick, S.D., α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo. Neuropharmacol 63 (2012), 434–440.
26. [26] Mulle, C., Vidal, C., Benoit, P., Changeus, J.P., Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo-interpeduncular system. J. Neurosci. 8 (1991), 2588–2597.
27. [27] Murtra, P., Sheasby, A.M., Hunt, S.P., De Felipe, C., Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405 (2000), 180–183.
28. [28] Nakaya, Y., Kaneko, T., Shigemoto, R., Shigetada, N., Mizuno, N., Immunohisotchemical localization of substance P receptor in the central nervous system of the adult rat. J. Comp. Neurol. 347 (1994), 249–274.
29. [29] Nisell, M., Nomikos, G.G., Svensson, T.H., Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16:1991 (1994), 36–44.
30. [30] Paxinos, G., Watson, C., The Rat Brain Stereotactic Coordinates. Second ed., 1986, Academic Press.
31. [31] Perry, D.C., Kellar, K.J., [3H] Epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. J. Pharmacol. Exp. Ther. 276 (1995), 1030–1034.
32. [32] Placenza, F.M., Fletcher, P.J., Vaccarino, F.J., Erb, S., Effects of central neurokinin-1 receptor antagonism on cocaine- and opiate-induced locomotor activity and self-administration behavior in rats. Pharmacol. Biochem. Behav. 84 (2006), 94–101.
33. [33] Quick, M.W., Ceballos, M.R., Kasten, M., McIntosh, M.J., Lester, R.A., α3β4 subunit-containing nicotinic receptors dominate function in the medial habenula neurons. Neuropharmacol 38 (1999), 769–783.
34. [34] Robinson, J.E., Fish, E.W., Krouse, M.C., Thorsell, A., Heilig, M., Malanga, C.J., Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism. Psychopharmacol (Berl.) 220 (2012), 215–224.
35. [35] Robinson, T.E., Berridge, K.C., The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. 18 (1993), 247–291.
36. [36] Saal, D., Dong, Y., Bonci, A., Malenka, R.C., Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37 (2003), 577–582.
37. [37] Salas, R., Pieri, F., De Biasi, M., Decreased signs of nicotine withdrawal in mice null for the β4 nicotinic acetylcholine receptor subunit. J. Neurosci. 24 (2004), 10035–10039.
38. [38] Salas, R., Sturm, R., Boulter, J., De Biasi, M., Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. J. Neurosci. 29 (2009), 3014–3018.
39. [39] Schank, J.R., King, C.E., Sun, H., Cheng, K., Rice, K.C., Heilig, M., Weinshenker, D., Schroeder, J.P., The role of the neurokinin-1 receptor in stress-induced reinstatement of alcohol and cocaine seeking. Neuropsychopharmacol 39 (2014), 1093–1101.
40. [40] Schank, J.R., Pickens, C.L., Rowe, K.E., Cheng, K., Thorsell, A., Rice, K.C., Shaham, Y., Heilig, M., Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429. Psychopharmacol (Berl.) 218 (2011), 111–119.
41. [41] Shih, P.Y., Engle, S.E., Oh, G., Deshpande, P., Puskar, N.L., Lester, H.A., Drenan, R.M., Differential expression and function of nicotinic acetylcholine receptors in subdivisions of medial habenula. J. Neurosci. 34 (2014), 9789–9802.
42. [42] Steketee, J.D., Kalivas, P.W., Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol. Rev. 63 (2011), 348–365.
43. [43] Sutherland, R.J., Nakajima, S., Self-stimulation of the habenular complex in the rat. J. Comp. Physiol. Psychol. 95 (1981), 781–791.
44. [44] Thorsell, A., Schank, J.R., Singley, E., Hunt, S.P., Heilig, M., Neurokinin-1 receptors (NK1Rs) alcohol consumption, and alcohol reward in mice. Psychopharmacol (Berl.) 209 (2010), 103–111.
45. [45] Toll, L., Zaveri, N.T., Polgar, W.E., Jiang, F., Khroyan, T.V., Zhou, W., Xie, X., Stauber, G.B., Costello, M.R., Leslie, F.M., AT-1001: A high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats. Neuropsychopharmacology 37 (2012), 1367–1376.
46. [47] Yip, J., Chahl, L.A., Localization of NK1 and NK3 receptors in guinea-pig brain. Regul. Pept. 98 (2001), 55–62.
47. [48] Zoli, M., Moretti, M., Zanardi, A., McIntosh, M.J., Clementi, F., Gotti, C., Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J. Neurosci. 22 (2002), 8785–8789.